IM Cannabis Terminates The Panaxia Pharmacy Option

The consideration payable by the company under the Panaxia transaction was CA$7.2 million ($5.3 million), comprised of CA$2.9 million in cash, payable in two installments, and $4.3 million in common shares, payable in five installments. To date, the company preformed four installments.

The Panaxia transaction included a further option to acquire, for no additional consideration, a pharmacy, including requisite licenses to dispense and sell medical cannabis to patients.

Price Action

IM Cannabis shares were trading 4.8% higher at $1.069 per share at the time of writing Monday morning.

Benzinga's Cannabis Capital Conference Is Back

Photo: Benzinga edit with photos by Matthias Zomer on Pexels and squarefrog on Pixabay

 

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.